CGAS and neoplasm: Importantly, cGAS was essential for the therapeutic effect of PD-L1 antibody as no therapeutic effect was observed in antibody-treated cGAS-deficient mice implanted with tumors: this is due to the need for activation of tumor-specific T cells to precede immune checkpoint inhibitor therapy.54